Industry: Service & Software
Published Date: 2026-03-26
Pages: 138 Pages
Report ld: 6342161
Request Sample
Customized Report
The global Meso Scale Discovery (MSD) Assay Services market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
An Meso Scale Discovery (MSD) Assay Services provide high-sensitivity, multiplex immunoassays for the quantitative measurement of biomarkers, proteins, and other analytes in biological samples. MSD assays are based on electrochemiluminescence detection, which offers several advantages over traditional ELISA, including increased sensitivity, a broader dynamic range, and the ability to measure multiple analytes simultaneously.
From a downstream perspective, Pharmaceutical Research accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).
Meso Scale Discovery (MSD) Assay Services leading players (including Chimera Biotec, Reaction Biology, NorthEast BioAnalytical Laboratories LLC, Creative Proteomics, Pestka Biomedical Laboratories, Inc, Precision Medicine Group, LLC, CellCarta, ImmunoDiagnostics Limited, Alcyomics Ltd, IMMUNOLOGIX, etc.), dominate supply; the top five capture approximately % of global revenue, with Chimera Biotec leading 2025 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Meso Scale Discovery (MSD) Assay Services market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the Meso Scale Discovery (MSD) Assay Services study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments
Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Meso Scale Discovery (MSD) Assay Services: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Meso Scale Discovery (MSD) Assay Services Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 S-Plex Technology
1.2.3 V-Plex Technology
1.2.4 Other
1.3 Market Segmentation by Application
1.3.1 Global Meso Scale Discovery (MSD) Assay Services Market Size by Application, 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical Research
1.3.3 Clinical Diagnostics
1.3.4 Biomarker Discovery
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Meso Scale Discovery (MSD) Assay Services Revenue Estimates and Forecasts (2021-2032)
2.2 Global Meso Scale Discovery (MSD) Assay Services Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competitive Landscape
3.1 Global Meso Scale Discovery (MSD) Assay Services Players’ Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2021-2026)
3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Players (2021 vs 2025)
3.2 Global Meso Scale Discovery (MSD) Assay Services Companies Headquarters and Service Footprint
3.3 Key Player Market Share by Product Type
3.3.1 S-Plex Technology: Market Share by Key Players
3.3.2 V-Plex Technology: Market Share by Key Players
3.3.3 Other: Market Share by Key Players
3.4 Global Meso Scale Discovery (MSD) Assay Services Market Concentration and Dynamics
3.4.1 Global Market Concentration
3.4.2 Market Entry and Exit Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Product Segmentation
4.1 Global Meso Scale Discovery (MSD) Assay Services Market by Type
4.1.1 Global Revenue by Type (2021-2032)
4.1.2 Global Revenue-Based Market Share by Type (2021-2032)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Meso Scale Discovery (MSD) Assay Services Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.1.2 Revenue-Based Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2021-2032)
6.2 North America Key Players’ Revenue in 2025
6.3 North America Meso Scale Discovery (MSD) Assay Services Market Size by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Meso Scale Discovery (MSD) Assay Services Market Size by Country
6.5.1 North America Revenue Trends by Country
6.5.2 US
6.5.3 Canada
6.5.4 Mexico
7 Europe
7.1 Europe Market Size (2021-2032)
7.2 Europe Key Players’ Revenue in 2025
7.3 Europe Meso Scale Discovery (MSD) Assay Services Market Size by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Meso Scale Discovery (MSD) Assay Services Market Size by Country
7.5.1 Europe Revenue Trends by Country
7.5.2 Germany
7.5.3 France
7.5.4 U.K.
7.5.5 Italy
7.5.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2021-2032)
8.2 Asia-Pacific Key Players’ Revenue in 2025
8.3 Asia-Pacific Meso Scale Discovery (MSD) Assay Services Market Size by Application (2021-2032)
8.4 Asia-Pacific Growth Accelerators and Market Barriers
8.5 Asia-Pacific Meso Scale Discovery (MSD) Assay Services Market Size by Region
8.5.1 Asia-Pacific Revenue Trends by Region
8.6 China
8.7 Japan
8.8 South Korea
8.9 Australia
8.10 India
8.11 Southeast Asia
8.11.1 Indonesia
8.11.2 Vietnam
8.11.3 Malaysia
8.11.4 Philippines
8.11.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2021-2032)
9.2 Central and South America Key Players’ Revenue in 2025
9.3 Central and South America Meso Scale Discovery (MSD) Assay Services Market Size by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Meso Scale Discovery (MSD) Assay Services Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2021-2032)
10.2 Middle East and Africa Key Players’ Revenue in 2025
10.3 Middle East and Africa Meso Scale Discovery (MSD) Assay Services Market Size by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Meso Scale Discovery (MSD) Assay Services Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Israel
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Chimera Biotec
11.1.1 Chimera Biotec Corporation Information
11.1.2 Chimera Biotec Business Overview
11.1.3 Chimera Biotec Meso Scale Discovery (MSD) Assay Services Product Features and Attributes
11.1.4 Chimera Biotec Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)
11.1.5 Chimera Biotec Meso Scale Discovery (MSD) Assay Services Revenue by Product in 2025
11.1.6 Chimera Biotec Meso Scale Discovery (MSD) Assay Services Revenue by Application in 2025
11.1.7 Chimera Biotec Meso Scale Discovery (MSD) Assay Services Revenue by Geographic Area in 2025
11.1.8 Chimera Biotec Meso Scale Discovery (MSD) Assay Services SWOT Analysis
11.1.9 Chimera Biotec Recent Developments
11.2 Reaction Biology
11.2.1 Reaction Biology Corporation Information
11.2.2 Reaction Biology Business Overview
11.2.3 Reaction Biology Meso Scale Discovery (MSD) Assay Services Product Features and Attributes
11.2.4 Reaction Biology Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)
11.2.5 Reaction Biology Meso Scale Discovery (MSD) Assay Services Revenue by Product in 2025
11.2.6 Reaction Biology Meso Scale Discovery (MSD) Assay Services Revenue by Application in 2025
11.2.7 Reaction Biology Meso Scale Discovery (MSD) Assay Services Revenue by Geographic Area in 2025
11.2.8 Reaction Biology Meso Scale Discovery (MSD) Assay Services SWOT Analysis
11.2.9 Reaction Biology Recent Developments
11.3 NorthEast BioAnalytical Laboratories LLC
11.3.1 NorthEast BioAnalytical Laboratories LLC Corporation Information
11.3.2 NorthEast BioAnalytical Laboratories LLC Business Overview
11.3.3 NorthEast BioAnalytical Laboratories LLC Meso Scale Discovery (MSD) Assay Services Product Features and Attributes
11.3.4 NorthEast BioAnalytical Laboratories LLC Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)
11.3.5 NorthEast BioAnalytical Laboratories LLC Meso Scale Discovery (MSD) Assay Services Revenue by Product in 2025
11.3.6 NorthEast BioAnalytical Laboratories LLC Meso Scale Discovery (MSD) Assay Services Revenue by Application in 2025
11.3.7 NorthEast BioAnalytical Laboratories LLC Meso Scale Discovery (MSD) Assay Services Revenue by Geographic Area in 2025
11.3.8 NorthEast BioAnalytical Laboratories LLC Meso Scale Discovery (MSD) Assay Services SWOT Analysis
11.3.9 NorthEast BioAnalytical Laboratories LLC Recent Developments
11.4 Creative Proteomics
11.4.1 Creative Proteomics Corporation Information
11.4.2 Creative Proteomics Business Overview
11.4.3 Creative Proteomics Meso Scale Discovery (MSD) Assay Services Product Features and Attributes
11.4.4 Creative Proteomics Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)
11.4.5 Creative Proteomics Meso Scale Discovery (MSD) Assay Services Revenue by Product in 2025
11.4.6 Creative Proteomics Meso Scale Discovery (MSD) Assay Services Revenue by Application in 2025
11.4.7 Creative Proteomics Meso Scale Discovery (MSD) Assay Services Revenue by Geographic Area in 2025
11.4.8 Creative Proteomics Meso Scale Discovery (MSD) Assay Services SWOT Analysis
11.4.9 Creative Proteomics Recent Developments
11.5 Pestka Biomedical Laboratories, Inc
11.5.1 Pestka Biomedical Laboratories, Inc Corporation Information
11.5.2 Pestka Biomedical Laboratories, Inc Business Overview
11.5.3 Pestka Biomedical Laboratories, Inc Meso Scale Discovery (MSD) Assay Services Product Features and Attributes
11.5.4 Pestka Biomedical Laboratories, Inc Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)
11.5.5 Pestka Biomedical Laboratories, Inc Meso Scale Discovery (MSD) Assay Services Revenue by Product in 2025
11.5.6 Pestka Biomedical Laboratories, Inc Meso Scale Discovery (MSD) Assay Services Revenue by Application in 2025
11.5.7 Pestka Biomedical Laboratories, Inc Meso Scale Discovery (MSD) Assay Services Revenue by Geographic Area in 2025
11.5.8 Pestka Biomedical Laboratories, Inc Meso Scale Discovery (MSD) Assay Services SWOT Analysis
11.5.9 Pestka Biomedical Laboratories, Inc Recent Developments
11.6 Precision Medicine Group, LLC
11.6.1 Precision Medicine Group, LLC Corporation Information
11.6.2 Precision Medicine Group, LLC Business Overview
11.6.3 Precision Medicine Group, LLC Meso Scale Discovery (MSD) Assay Services Product Features and Attributes
11.6.4 Precision Medicine Group, LLC Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)
11.6.5 Precision Medicine Group, LLC Recent Developments
11.7 CellCarta
11.7.1 CellCarta Corporation Information
11.7.2 CellCarta Business Overview
11.7.3 CellCarta Meso Scale Discovery (MSD) Assay Services Product Features and Attributes
11.7.4 CellCarta Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)
11.7.5 CellCarta Recent Developments
11.8 ImmunoDiagnostics Limited
11.8.1 ImmunoDiagnostics Limited Corporation Information
11.8.2 ImmunoDiagnostics Limited Business Overview
11.8.3 ImmunoDiagnostics Limited Meso Scale Discovery (MSD) Assay Services Product Features and Attributes
11.8.4 ImmunoDiagnostics Limited Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)
11.8.5 ImmunoDiagnostics Limited Recent Developments
11.9 Alcyomics Ltd
11.9.1 Alcyomics Ltd Corporation Information
11.9.2 Alcyomics Ltd Business Overview
11.9.3 Alcyomics Ltd Meso Scale Discovery (MSD) Assay Services Product Features and Attributes
11.9.4 Alcyomics Ltd Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)
11.9.5 Alcyomics Ltd Recent Developments
11.10 IMMUNOLOGIX
11.10.1 IMMUNOLOGIX Corporation Information
11.10.2 IMMUNOLOGIX Business Overview
11.10.3 IMMUNOLOGIX Meso Scale Discovery (MSD) Assay Services Product Features and Attributes
11.10.4 IMMUNOLOGIX Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)
11.10.5 Company Ten Recent Developments
11.11 Novogene
11.11.1 Novogene Corporation Information
11.11.2 Novogene Business Overview
11.11.3 Novogene Meso Scale Discovery (MSD) Assay Services Product Features and Attributes
11.11.4 Novogene Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)
11.11.5 Novogene Recent Developments
11.12 Guidon Pharmaceutics
11.12.1 Guidon Pharmaceutics Corporation Information
11.12.2 Guidon Pharmaceutics Business Overview
11.12.3 Guidon Pharmaceutics Meso Scale Discovery (MSD) Assay Services Product Features and Attributes
11.12.4 Guidon Pharmaceutics Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)
11.12.5 Guidon Pharmaceutics Recent Developments
11.13 MEDx Translational Medicine Co., Ltd
11.13.1 MEDx Translational Medicine Co., Ltd Corporation Information
11.13.2 MEDx Translational Medicine Co., Ltd Business Overview
11.13.3 MEDx Translational Medicine Co., Ltd Meso Scale Discovery (MSD) Assay Services Product Features and Attributes
11.13.4 MEDx Translational Medicine Co., Ltd Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)
11.13.5 MEDx Translational Medicine Co., Ltd Recent Developments
12 Meso Scale Discovery (MSD) Assay Services Value Chain and Ecosystem Analysis
12.1 Meso Scale Discovery (MSD) Assay Services Value Chain (Ecosystem Structure)
12.2 Upstream Analysis
12.2.1 Key Technologies, Platforms and Infrastructure
12.3 Midstream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Meso Scale Discovery (MSD) Assay Services Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Meso Scale Discovery (MSD) Assay Services Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Meso Scale Discovery (MSD) Assay Services market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 91
USD 4250.00
(Single User License)
The global market for Meso Scale Discovery (MSD) Assay Services was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 116
USD 3950.00
(Single User License)
The global Meso Scale Discovery (MSD) Assay Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 111
USD 2900.00
(Single User License)
The global Meso Scale Discovery (MSD) Assay Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 92
USD 4250.00
(Single User License)
The global Meso Scale Discovery (MSD) Assay Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 138
USD 4900.00
(Single User License)
The global market for Meso Scale Discovery (MSD) Assay Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 115
USD 3950.00
(Single User License)
The global market for Meso Scale Discovery (MSD) Assay Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 82
USD 2900.00
(Single User License)
An Meso Scale Discovery (MSD) Assay Services provide high-sensitivity, multiplex immunoassays for the quantitative measurement of biomarkers, proteins, and other analytes in biological samples. MSD assays are based on electrochemiluminescence detection, which offers several advantages over traditional ELISA, including increased sensitivity, a broader dynamic range, and the ability to measure multiple analytes simultaneously.
Published Date: 2024-07-20
Pages: 86
USD 2900.00
(Single User License)
An Meso Scale Discovery (MSD) Assay Services provide high-sensitivity, multiplex immunoassays for the quantitative measurement of biomarkers, proteins, and other analytes in biological samples. MSD assays are based on electrochemiluminescence detection, which offers several advantages over traditional ELISA, including increased sensitivity, a broader dynamic range, and the ability to measure multiple analytes simultaneously.
Published Date: 2024-07-20
Pages: 111
USD 4350.00
(Single User License)
An Meso Scale Discovery (MSD) Assay Services provide high-sensitivity, multiplex immunoassays for the quantitative measurement of biomarkers, proteins, and other analytes in biological samples. MSD assays are based on electrochemiluminescence detection, which offers several advantages over traditional ELISA, including increased sensitivity, a broader dynamic range, and the ability to measure multiple analytes simultaneously.
Published Date: 2024-07-20
Pages: 139
USD 4900.00
(Single User License)
The global Meso Scale Discovery (MSD) Assay Services market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 91
The global market for Meso Scale Discovery (MSD) Assay Services was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 116
The global Meso Scale Discovery (MSD) Assay Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 111
The global Meso Scale Discovery (MSD) Assay Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 92
The global Meso Scale Discovery (MSD) Assay Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 138
The global market for Meso Scale Discovery (MSD) Assay Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 115
The global market for Meso Scale Discovery (MSD) Assay Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 82
An Meso Scale Discovery (MSD) Assay Services provide high-sensitivity, multiplex immunoassays for the quantitative measurement of biomarkers, proteins, and other analytes in biological samples. MSD assays are based on electrochemiluminescence detection, which offers several advantages over traditional ELISA, including increased sensitivity, a broader dynamic range, and the ability to measure multiple analytes simultaneously.
Published: 2024-07-20
Pages: 86
An Meso Scale Discovery (MSD) Assay Services provide high-sensitivity, multiplex immunoassays for the quantitative measurement of biomarkers, proteins, and other analytes in biological samples. MSD assays are based on electrochemiluminescence detection, which offers several advantages over traditional ELISA, including increased sensitivity, a broader dynamic range, and the ability to measure multiple analytes simultaneously.
Published: 2024-07-20
Pages: 111
An Meso Scale Discovery (MSD) Assay Services provide high-sensitivity, multiplex immunoassays for the quantitative measurement of biomarkers, proteins, and other analytes in biological samples. MSD assays are based on electrochemiluminescence detection, which offers several advantages over traditional ELISA, including increased sensitivity, a broader dynamic range, and the ability to measure multiple analytes simultaneously.
Published: 2024-07-20
Pages: 139
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now